Familial adenomatous polyposis (FAP) patients develop various extracolonic lesions, among which functional adrenocortical neoplasms are infrequent. A 44-year-old woman was hospitalized because of pseudo-Meigs' syndrome, caused by bilateral ovarian metastases from an advanced ascending colon cancer due to FAP of intermediate type. Furthermore, bilateral adrenocortical adenomas were detected, and functional analyses showed a hormonal secretion pattern consistent with Cushing's syndrome. She underwent a right hemicolectomy with extirpation of bilateral ovaries. At 10 months post-operative with no detectable metastatic lesions, the residual colorectum and the larger, left adrenal gland were resected, and the hormonal hypersecretion was normalized. Direct sequencing of the adenomatous polyposis coli (APC) gene revealed a nonsense germline mutation at codon 1577 and an additional nonsense somatic mutation at codon 554 in cancer tissues. Biallelic APC inactivation due to loss of the normal allele was evident in the adrenocortical adenoma. There were no hypermethylated CpG islands detected in APC promoter regions. Immunostaining for b-catenin revealed diffuse cytoplasmic expression in resected tissues including adrenocortical adenoma. Biallelic APC inactivation may play a role in developing cortisol-secreting adrenocortical adenoma in FAP patients. It is noteworthy that biallelic APC inactivation was caused in different ways in different tumors from the same individual.
INTRODUCTION
Familial adenomatous polyposis (FAP), which affects 1 in 13 000 births (1) , is an autosomal-dominant colorectal cancer syndrome caused by a germline mutation in the adenomatous polyposis coli (APC) gene located on chromosome 5q21-22. The most striking feature of FAP is the development of hundreds to thousands of adenomatous polyps throughout the colon in their second and third decades of life, which inevitably progress to colorectal carcinoma by the age of 40-50 years if left untreated.
FAP patients develop not only colorectal adenomas, but also various extracolonic lesions, including upper gastrointestinal polyps, congenital hypertrophy of the retinal pigment epithelium, desmoid tumors, thyroid cancers, osteomas, cutaneous lipomas and cysts, hepatoblastomas, and adrenocortical adenomas. The majority of the adrenal masses detected incidentally (incidentalomas) in FAP are nonfunctioning (2, 3) , and cortisol-secreting adrenal tumors are rarely associated with FAP (4, 5) . Herein, we report an extremely rare case of an FAP patient presenting with pseudo-Meigs' syndrome caused by an advanced ascending colon cancer with bilateral ovarian metastases, complicated by hypertension due to bilateral cortisol-secreting adrenocortical adenomas. The molecular mechanisms responsible for colonic and extracolonic tumors are discussed based on the genetic and epigenetic alterations of the APC tumor suppressor gene.
CASE REPORT
A 44-year-old woman was admitted to Kyoto University Hospital because of severe dyspnea and abdominal distention due to massive pleural effusion and ascites, without any remarkable past history ( Fig. 1A and B) . Her father and her aunt died of colorectal cancer in their 50s, and her brother was recently diagnosed with colonic polyposis (Fig. 1C) . Her height and weight were 173 cm and 96.5 kg (body mass index 32.2), and her blood pressure was 148/96 mmHg ( Table 1) . Laboratory findings showed a total cholesterol of 243 mg/dl; triglyceride, 190 mg/dl; CEA, 46.8 ng/ml (,5.0); CA19-9, 46.2 U/ml (,37); and CA125, 2692 U/ml (,35) ( Table 1) . Immediately, a chest suction tube was placed for drainage of the massive right pleural effusion. Although her respiratory condition was improved, the pleural effusion continued to drain at 2000 ml every day. Cytological examinations failed to confirm any malignant effusion. Computed tomography (CT) scans of the abdomen demonstrated a moderate amount of ascites (Fig. 1B) , irregular wall thickening of the ascending colon (Fig. 1D) , huge cystic bilateral ovarian tumors with a solid portion (right, 15 cm; left, 7 cm in diameter) (Fig. 1E ) and pathological swelling of bilateral adrenal glands (right, 14 mm; left, 30 mm in diameter) ( Fig. 1B and F) . A subsequent total colonoscopy revealed a circumferential, advanced cancer in the ascending colon ( Fig. 1G ) and multiple polyps (150) predominantly located in the right side of the colon. Positron emission tomography with 18-fluorodeoxyglucose scans revealed strong uptake signals in the colon cancer and bilateral ovarian tumors (Fig. 1H ), but no detectable signals in the bilateral adrenal tumors, suggesting the possibility of benign adrenal adenomas rather than metastatic lesions from the colon cancer. Subsequent adsterol scintigraphy confirmed hyperfunction of the bilateral adrenal glands, with more prominent signal intensities in the left adrenal gland when compared with the right (Fig. 1I) . Endocrinologic functional analyses of the adrenal glands revealed the hypersecretion of cortisol, aldosterone and testosterone, and the cortisol secretion was not suppressed by the administration of 1 mg dexamethasone (Table 1) . These hormonal secretion patterns suggested the development of Cushing's syndrome, accompanied by hypertension and obesity. In addition, she had multiple osteomas in the mandibular bones, multiple gastric polyps and thyroid nodules, which were diagnosed as adenomatous goiter by aspiration biopsy. These clinical data led to the presumptive diagnosis of FAP, complicated by advanced colon cancer and bilateral ovarian metastases, resulting in the refractory retention of massive right-sided pleural effusion and ascites ( pseudo-Meigs' syndrome). Since there was a chance to improve her condition by surgical intervention, she underwent a right hemicolectomy with radical dissection of the regional lymph nodes and complete extirpation of bilateral ovaries ( Fig. 2A -E) . Post-operatively, the massive pleural effusion disappeared rapidly and ceased to recur. The resected ascending colon had 100 adenomatous polyps ( Fig. 2A -C) . Pathologically, the advanced colon cancer invaded into the serosal layer and had metastasized to the regional lymph nodes and bilateral ovaries ( Fig. 2D and E) . She underwent nine cycles of oxaliplatin-based adjuvant chemotherapy (FOLFOX) and another 5 months of oral chemotherapy with fluorouracil/leucovorin without any complications. At 10 months after the first operation without any evidence of recurrences or metastases, she requested that we extirpate the residual colorectum and swollen adrenal glands. She had several episodes of hematochezia even after the operation, which made her depressed and anxious about the progression of the residual colorectal polyps, and she was unwilling to continue surveillance colonoscopy. After the long discussion with her, we agreed to proceed with the extirpation of the residual colorectum, despite the absence of pathologically proven malignant lesions in the residual colorectum and presumably poor prognosis due to possible recurrences or metastases. After adequate informed consent was obtained, we performed a subtotal colectomy with ileorectal anastomosis and extirpation of the larger, left adrenal gland ( Fig. 2F -H) for the following reasons: (i) since there was still a strong possibility of recurrence or metastasis in the near future, her post-operative quality of life should have priority over an ideal treatment, (ii) since a right hemicolectomy had been performed, it was difficult to construct an ileal pouch and a proctocolectomy would result in a permanent ileostomy and (iii) a bilateral adrenectomy would oblige her to take regular steroid supplements for the rest of her life, and slightly swollen right adrenal gland could be functionally subclinical, since overt hyperfunction of the left adrenal gland, shown by pre-operative adsterol scintigraphy, undoubtedly caused the adrenal hyperfunctionism (Fig. 1I ). The resected colorectum had 50 adenomatous polyps, which were smaller and sparser than those in the ascending colon ( Fig. 2F and G) . Pathologically, the resected adrenal tumor was an adrenocortical adenoma with no malignant transformation (Fig. 2H ). In addition, the adrenal tumor was immunopositive for steroidogenic enzymes such as 3b-hydroxysteroid dehydrogenase (3b-HSD), 11b-hydroxylase (P450c11) and 17a-hydroxylase (P450c17) ( Fig. 3A -C ; data not shown for P450c17), indicating the production of cortisol in the adrenocortical adenoma. The post-operative course was uneventful, and her blood pressure and body mass index improved spontaneously ( Table 1 ). The post-operative laboratory data including tumor markers and endocrinologic functional assays also decreased to below cut-off values (Table 1) . Although she lived a daily life without any sequelae, follow-up CT scans taken at 9 months after the second operation revealed small nodules in the abdominal cavity, suggestive of peritoneal dissemination, and we initiated irinotecan-based systemic chemotherapy. Her endocrinologic data was within normal upper limits and
838
APC dysfunction in adrenal tumor in FAP 
Jpn J Clin Oncol 2009;39(12) 839
the right adrenal gland remained the same size during the follow-up period, suggesting that the residual adrenal tumor was still functionally subclinical. If the adrenal tumor grows apparently in size and causes severe adrenal hyperfunctionism, resection of the residual adrenal gland may be taken into consideration.
MOLECULAR PROFILES
Based upon a presumptive clinical diagnosis of FAP, she received genetic counseling at Genetic Counseling and Clinical Research Unit in Kyoto University, and written informed consent on further genetic analyses was obtained. Direct sequencing of the APC gene, including exon -intron boundaries, was performed on genomic DNA extracted from the primary colon cancer, metastatic ovarian tumors, three large colon polyps .10 mm in diameter, normal adrenal and adenoma tissues, normal colonic mucosa, and peripheral blood leukocytes. A nonsense germline heterozygous mutation (GAA(Glu)!TAA(STOP)) was detected at codon 1577 in exon 15 in the genomic DNA from the peripheral blood leukocytes, and an additional nonsense somatic heterozygous mutation (CGA(Arg)!TGA(STOP)) was evident at codon 554 in exon 13 in the primary colon cancer and metastatic ovarian tumors ( Fig. 4A and B) . Two of the three colon polyps examined had different somatic heterozygous mutations in exon 15 ( Fig. 4E and F and Table 2 ). No somatic mutations besides the germline mutation occurred in the normal colonic mucosa, normal adrenal gland, adrenocortical adenoma or the one remaining colon polyp examined. We further investigated other potential genetic or epigenetic inactivations of the APC gene, including allelic loss and promoter hypermethylation. Since the germline mutation at codon 1577 was homozygous in the adrenocortical adenoma (Fig. 4D) , the loss of the other wild-type allele was highly suspected. As compatible with the database of singlenucleotide polymorphisms (SNPs) (http://www.ncbi.nlm. nih.gov/SNP/) of the APC gene, heterozygous SNPs were Fig. 4G and I ). In contrast, the adrenocortical adenoma tissues showed homozygous SNPs at all of the codons ( Fig. 4H and J, and Table 2 ). The SNP data indicated the loss of the other wild-type allele ranging from at least codons 486 to 1756, leading to biallelic inactivation of the APC gene in the adrenocortical adenoma. We also examined the methylation status at CpG islands in the 5 0 main regulatory region (1A promoter) upstream of the APC gene using methylation-specific PCR (MSP) for genomic DNA modified chemically with sodium bisulfite (6). There was no evidence of promoter hypermethylation in any of the tissues examined ( Fig. 5 and Table 2 ). Next, the subcellular localizations of b-catenin, a key component in the Wnt signaling pathway, were examined immunohistochemically in the resected specimens. When compared the normal colonic mucosa with membranous immunostaining patterns, the primary colon cancer, metastatic ovarian tumors and colon polyps showed an enhanced cytoplasmic immunostaining for b-catenin (Fig. 3D -G) . The adrenocortical adenoma also showed diffuse cytoplasmic immunostaining, although the signal intensities were not as strong as the colon specimens (Fig. 3H) . The nuclear accumulation of b-catenin was not observed in any of these tissues. Immunohistochemical analysis for TP53, mutations of which are considered as late events in adenomacarcinoma progression (7), revealed dense, nuclear accumulation in the primary colon cancer (Fig. 3I ) and metastatic ovarian tumors (data not shown), whereas TP53 expression was not observed in normal colonic mucosa, colon polyps or the adrenocortical adenoma (Fig. 3J , data not shown).
DISCUSSION
The patient in this report presented with various clinical manifestations and provided many thought-provoking problems. We focused on the genotype -phenotype correlations in FAP patients, Knudson's two-hit hypothesis for the APC gene, biallelic inactivation of the APC gene and adrenocortical tumorigenesis. Previous reports described intriguing genotype -phenotype correlations between mutation sites and the severity of colorectal polyposis (8, 9) . FAP patients of the profuse type develop .5000 adenomas and have germline mutations in a hot spot termed the 'mutation cluster region' (MCR) (codons 1250 -1464). Another distinct subtype of attenuated FAP (AFAP) is characterized by fewer adenomas (,100) located mainly in the right side of the colon and by the later onset of colorectal cancers (mean age: 55 years). AFAP is associated with germline mutations at the 5 0 end (codons 1 -177), Immunohistochemical findings of the adrenal gland, colon and ovary tissues. Immunohistochemical staining for the steroidogenic enzymes 3b-hydroxysteroid dehydrogenase (3b-HSD) (B) and 11b-hydroxylase (P450c11) (C) on serial sections of the resected adrenocortical adenoma (A; hematoxylin and eosin). The tumor was immunopositive for 3b-HSD and P450c11, indicating the production of cortisol in the adrenocortical tumor. An immunohistochemical study for b-catenin showed a membraneous immunostaining pattern in the normal colonic mucosa (D), whereas a cytoplasmic immunostaining pattern was observed in the colon polyps (E), primary colon cancer (F) and metastatic ovarian tumors (G). (H) The adrenocortical adenoma also showed a diffuse cytoplasmic immunostaining pattern for b-catenin, although the signal intensities were not as strong as in the colon tissues. Immunostaining for TP53 in the primary colon cancer (I) and in the adrenocortical adenoma (J). Note that nuclear accumulation of TP53 was evident in colon cancer, whereas no specific expression was observed in the adrenocortical adenoma. The insets show higher magnification views of the boxed areas. Adrenocortical adenoma tissues (A -C, H and J) and primary colon cancer tissues (F and I) were stained on serial sections. Scale bar, 100 mm.
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APC dysfunction in adrenal tumor in FAP although colorectal adenomas (150) were fewer than anticipated. FAP patients inherit one germline mutation of the APC gene that causes a truncated non-functional protein in most cases, and develop colon polyps in their third or fourth decades when the colonic epithelial cells somatically acquire a second mutation in the APC gene or a loss of the other wild-type allele (11, 12) . Inactivation of both APC alleles is the critical first step and occurs at an early stage of tumor development (13) . According to the classical interpretation of Knudson's hypothesis, these 'two' hits are independent mutation events in the process of inactivation of the tumor suppressor gene. However, recent reports suggest that the APC gene does not entirely follow this model (11, 14) . The position and type of somatic mutations (the second hit) in the FAP polyps depend on the sites of the germline mutations (the first hit). In polyps from FAP patients with germline mutations around codon 1300, an allelic loss is the most common as the second hit. In contrast, polyps from patients with germline mutations outside this region (5 0 to codon 1190 or 3 0 to codon 1392) showed infrequent allelic losses but appeared to acquire the second hit by point mutations within the MCR (11). Furthermore, Albuquerque et al. (14) proposed a 'just-right' signaling model, in which specific APC genotypes are selected during tumor formation based on a residual activity of down-regulating the (12) 843 cytoplasmic levels of b-catenin. Specifically, a combination of germline and somatic mutations in the colon tumorigenesis was determined to encode a truncated protein retaining a specific number of 20AARs optimal for tumor formation, rather than deletion of all the 20AARs. As consistent with this hypothesis, a putative truncated protein caused by the germline mutation at codon 1577 in this case contained three 20AARs, which may still have an impaired ability to downregulate b-catenin, and an additional somatic mutation appeared at codon 554 in the cancer tissues and at codon 832 in one of the colon polyps, resulting in the deletion of all the 20AARs from the wild-type APC protein.
In this case, genetic biallelic inactivation of the APC gene was demonstrated in both primary and metastatic cancers, two of the three colon polyps and the adrenocortical adenoma, but one of the colon polyps lacked a second identifiable inactivating event on the remaining allele. As an epigenetic inactivator of the APC gene, promoter hypermethylation played a role in impairing APC function in 20% of the sporadic colon cancers (6) . There was no evidence of promoter hypermethylation in any of the tissues examined, which is consistent with the finding that promoter methylation was not observed in any of the FAP patients (6) . Although the mechanisms underlying the biallelic inactivation of the APC gene in one of the polyps remained unresolved, miRNA including miR-135 may suppress the expression of the APC gene post-transcriptionally, as proposed in a recent report (15) . We extendedly investigated genetic and epigenetic alterations of the APC gene and confirmed aberrant regulations of Wnt signaling pathway in almost all of the resected tissues including a rare extracolonic tumor, adrenocortical adenoma. Since there is 844 APC dysfunction in adrenal tumor in FAP still a paucity of genetic information on different colonic and extracolonic tumors from the same FAP patient (14) , this case provides another intriguing issue to be elucidated, in that biallelic inactivation may occur due to different mechanisms in different tumors from the same individual.
Immunohistochemical analyses of b-catenin revealed enhanced cytoplasmic expression in the colon polyps, colon cancer and metastatic ovarian tumors (Fig. 3) . Although biallelic inactivation of the APC gene was confirmed by genetic analyses, the nuclear accumulation of b-catenin was not observed in any of the tissues examined. The strong nuclear immunostaining of b-catenin is a well-documented immunohistochemical finding in APC-deficient tumor cells. However, previous reports showed that the nuclear translocation of b-catenin required more than biallelic APC inactivation in polyps from a FAP patient (16) , and that the nuclear overexpression of b-catenin was observed in only 42% of invasive colorectal cancers, and in none of colorectal adenomas, even with APC mutations (17) .
Some gene alterations, including TP53, insulin-like growth factor type-II and the regulatory R1A subunit of protein kinase A, are probably involved in the adrenocortical tumorigenesis (18) . However, the pathophysiology of adrenocortical tumors remains poorly characterized. Nuclear accumulation of TP53 was not observed in the adrenocortical adenoma (Fig. 3J ) in our case. The incidence of adrenal incidentalomas in FAP was reported at 7.4 -13%, which was higher than that in the general population (0.6 -3.4%) (2, 4) . Previous reports regarding adrenocortical tumors associated with FAP (2 -5,19) described the incidences, functionality and appropriate management of the tumors. However, important and intriguing issues on genotype -phenotype correlations of FAP-associated adrenal tumors and/or on possible correlations between the development of adrenal tumors and the status of colon polyposis are poorly characterized. So far, genetic analysis was performed in only one incidentaloma (19) , which showed a germline mutation with a loss of the normal allele as the cause of APC inactivation. On the other hand, several reports suggest that the Wnt/b-catenin signaling pathway is involved in the development of adrenocortical tumors (20, 21) . Mutations of the b-catenin gene were evident in 15 -27% of adrenocortical adenomas, and the enhanced cytoplasmic expression and/or nuclear accumulation of b-catenin were demonstrated immunohistochemically. Our detailed analyses in adrenocortical adenoma tissues confirmed that biallelic APC inactivation was due to a germline mutation along with the allelic loss resulting in the consequent enhanced cytoplasmic expression of b-catenin. With respect to the functional adrenal tumors in FAP, only three patients presented with Cushing's syndrome without any genetic analyses on the APC gene (4, 5) . This is the first report demonstrating that biallelic inactivation of the APC gene may play a role in the development of a functional adrenocortical adenoma responsible for Cushing's syndrome. Further studies in FAP patients are still required to elucidate a genotype -phenotype correlation in the development of adrenocortical tumors and to show a causative role for Wnt pathway activation in adrenocortical tumorigenesis and the subsequent hormone overproduction. 
METHODS

APC MUTATION ANALYSIS
Genomic DNA was extracted by conventional phenolchloroform purification from peripheral blood leukocytes and the resected tissues. The entire coding regions and exonintron boundaries of the APC gene were analyzed by PCR-based direct sequencing techniques. The primers used for PCR are shown in Table 3 .
IMMUNOHISTOCHEMISTRY
Formalin-fixed, paraffin-embedded serial sections of the resected tissues were immunostained with anti-b-catenin and anti-p53 antibodies (Novocastra, Newcastle upon Tyne, UK) by the avidin -biotin complex immunohistochemical technique. The adrenal tumor tissues were also immunostained with antibodies for 3b-HSD, P450c17 and P450c11 as described previously (22) . Microwave antigen retrieval was performed.
METHYLATION-SPECIFIC PCR
Complete bisulfite conversion of the genomic DNA was performed with an EpiTect Bisulfite Kit (Qiagen, CA, USA) according to the manufacturer's instructions. DNA methylation patterns in the main promoter region (1A promoter) of the APC gene, including CpG islands, were analyzed in DNA samples extracted from peripheral blood leukocytes and the resected tissues, as described previously (6) . In vitro methylated DNA was used as a positive control for the methylated genes.
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